In one phase 2 study: Pancreatitis was reported in about 0.4% of participants (1 out of 267) Gallbladder issues affected roughly 1.1%, with no cases in the placebo group Heart rhythm changes were reported more often in people taking retatrutide (about 6% compared to 3% with placebo) Liver enzyme increases were rare (around 1%), and overall liver health markers stayed stable over time
Watch the full episode: www.youtube.com/watch?v=GGfrESBX0DQ #GLP1 #Podcast #Compliance #Semaglutide #Tirzepatide | Lengea Law
Peptide therapies have become one of the most discussed topics in longevity, recovery, body composition, and performance medicine
Lack of glutathione contributes to oxidative stress, which plays a key role in lung disease, osteoarthritis, cataracts, glaucoma, chemotherapy, and cancer, as well as Alzheimers disease and Parkinsons disease (Wu et al., 2004)
No single Hb cutoff exists the answer is case-by-case
Inflammatory signaling